Peptides Lack Reliable Safety Information, Watchdog Warns FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC I spent 4 months reporting on the peptide BPC 157 and its unlikely journey from a research lab in post communist Croatia to today's MAHA movement. Ask me anything. : r IAmA Safety of Recombinant Activated Factor VII in Randomized Clinical Trials New England Journal of Medicine The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and